Aastrom Biosciences, Inc.

Aastrom Biosciences, Inc. is a leading U.S. manufacturer of patient-specific stem cell therapies that are designed to treat persistent, severe cardiovascular conditions such as congestive heart failure and peripheral arterial disease. The company’s research and development efforts are centered on creating an individualized multicellular therapy called ixmyelocel-T that is derived from stem cells originating in each patient’s own bone marrow. The bone marrow is extracted and subjected to Aastrom’s proprietary cell-processing technology, which stimulates natural production of various cell types that play key roles in tissue repair and healing. The processed marrow is delivered back into the patient’s damaged tissue by way of direct infusion, injection, or transplant to promote sustained restoration of tissues and organs. Aastrom expanded its cell therapy portfolio in 2014 with ...